Dexcom (DXCM) Return on Capital Employed (2011 - 2026)
Dexcom (DXCM) reported Return on Capital Employed of 24.24% for Q1 2026, up 658.0% year-over-year from 3.2% in Q1 2025, and up 27.02% on a QoQ basis from 19.09% in Q4 2025.
Dexcom (DXCM) has 16 years of Return on Capital Employed data on file, last reported at 24.24% in Q1 2026.
- Quarterly Return on Capital Employed rose 658.0% year-over-year to 24.24% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 24.24% (up 658.0% YoY) and the FY2025 annual result came in at 21.36%, up 393.0% from the prior year.
- Return on Capital Employed climbed to 24.24% in Q1 2026 per DXCM's latest filing, from 19.09% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 24.24% in Q1 2026 and bottomed at 5.48% in Q2 2022.
- The 5-year median for Return on Capital Employed is 12.97% (2024), against an average of 13.55%.
- The widest annual swing landed in 2022, when Return on Capital Employed tumbled 349 bps; it then jumped 658 bps in 2026.
- Tracing DXCM's Return on Capital Employed over 5 years: stood at 11.83% in 2022, then rose by 4 bps to 12.26% in 2023, then jumped by 40 bps to 17.21% in 2024, then rose by 11 bps to 19.09% in 2025, then grew by 27 bps to 24.24% in 2026.
- Per Business Quant, the three latest DXCM Return on Capital Employed figures stand at 24.24% (Q1 2026), 19.09% (Q4 2025), and 19.07% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 5.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.24% |
| Dec 31, 2025 | 19.09% |
| Sep 30, 2025 | 19.07% |
| Jun 30, 2025 | 18.42% |
| Mar 31, 2025 | 17.67% |
| Dec 31, 2024 | 17.21% |
| Sep 30, 2024 | 12.97% |
| Jun 30, 2024 | 13.86% |
| Mar 31, 2024 | 13.63% |
| Dec 31, 2023 | 12.26% |
| Sep 30, 2023 | 10.06% |
| Jun 30, 2023 | 10.94% |
| Mar 31, 2023 | 11.06% |
| Dec 31, 2022 | 11.83% |
| Sep 30, 2022 | 6.41% |
| Jun 30, 2022 | 5.48% |
| Mar 31, 2022 | 6.10% |
| Dec 31, 2021 | 6.43% |
| Sep 30, 2021 | 9.45% |
| Jun 30, 2021 | 8.97% |
| Mar 31, 2021 | 8.35% |
| Dec 31, 2020 | 8.69% |
| Sep 30, 2020 | 9.37% |
| Jun 30, 2020 | 10.02% |
| Mar 31, 2020 | 9.15% |
| Dec 31, 2019 | 7.37% |
| Sep 30, 2019 | -6.86% |
| Jun 30, 2019 | -9.58% |
| Mar 31, 2019 | -9.94% |
| Dec 31, 2018 | -14.41% |
| Sep 30, 2018 | -1.12% |
| Jun 30, 2018 | -3.08% |
| Mar 31, 2018 | -4.23% |
| Dec 31, 2017 | -5.79% |
| Sep 30, 2017 | -8.64% |
| Jun 30, 2017 | -14.93% |
| Mar 31, 2017 | -32.32% |
| Dec 31, 2016 | -22.83% |
| Sep 30, 2016 | -21.51% |
| Jun 30, 2016 | -33.07% |
| Mar 31, 2016 | -27.46% |
| Dec 31, 2015 | -27.52% |
| Sep 30, 2015 | -31.94% |
| Jun 30, 2015 | -12.34% |
| Mar 31, 2015 | -14.60% |
| Dec 31, 2014 | -16.36% |
| Sep 30, 2014 | -23.31% |
| Jun 30, 2014 | -27.09% |
| Mar 31, 2014 | -32.23% |
| Dec 31, 2013 | -34.32% |
| Sep 30, 2013 | -44.29% |
| Jun 30, 2013 | -58.40% |
| Mar 31, 2013 | -59.40% |
| Dec 31, 2012 | -65.61% |
| Sep 30, 2012 | -69.14% |
| Jun 30, 2012 | -57.20% |
| Mar 31, 2012 | -46.85% |
| Dec 31, 2011 | -40.75% |
| Sep 30, 2011 | -36.04% |